Sun Pharma Advanced Research Company Limited has informed the Exchange about Recording of Audio Playback of the Investor Presentation for Update on Clinical Programs and R&D Pipeline

SPARC/Sec/SE/2022-23/061

October 17, 2022

National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051.

BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001.

Ref: Scrip Code: NSE: SPARC; BSE: 532872

Dear Sir/Madam,

Sub: Audio Playback of the Investor Presentation for Update on Clinical Programs and R&D

Pipeline

Further to our letters dated September 29, 2022 and October 13, 2022 bearing reference nos. SPARC/Sec/SE/2022-23/056 and SPARC/Sec/SE/2022-23/060 respectively, please note that the Investor Presentation was made as per the scheduled time. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby share the Audio Playback of the said Investor Presentation which can be accessed until Saturday, October 29, 2022 using the below mentioned dial in details:

Dial-in Numbers:

India (+91 22 71945757) Hong Kong Toll Free (800965553) Singapore Toll Free (8001012510) UK Toll Free (8007563427) India (+91 22 66635757) Toll Free USA (183328983 17) USA Toll (13479747488)

Playback Code: 27135

This is for your information and dissemination.

Yours faithfully,

For Sun Pharma Advanced Research Company Ltd.

Dinesh Lahoti Company Secretary and Compliance Officer ICSI Membership No. A22471